메뉴 건너뛰기




Volumn 27, Issue 2, 2000, Pages 111-115

Are the triptans for migraine therapy worth the cost?

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUTORPHANOL; CAFERGOT; DICLOFENAC POTASSIUM; DIHYDROERGOTAMINE; IBUPROFEN; METOCLOPRAMIDE; NARATRIPTAN; PARACETAMOL; SUMATRIPTAN; TOLFENAMIC ACID; ZOLMITRIPTAN;

EID: 0034129789     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100052197     Document Type: Review
Times cited : (11)

References (24)
  • 1
    • 0031760112 scopus 로고    scopus 로고
    • Efficacy and adverse events of subcutaneous, oral and intranasal sumatriptan used for migraine treatment: A systematic review based on number needed to treat
    • Oct
    • Tfelt-Hansen P. Efficacy and adverse events of subcutaneous, oral and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat. Cephalalgia 1998 Oct:18(8):532-538.
    • (1998) Cephalalgia , vol.18 , Issue.8 , pp. 532-538
    • Tfelt-Hansen, P.1
  • 3
    • 0030009441 scopus 로고    scopus 로고
    • Subcutaneous sumatriptan for the treatment of migraine: Humanistic, economic, and clinical consequences
    • Mar
    • Cohen JA, Beall DG, Miller DW, et al. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences. Fam Med 1996 Mar:28(3):171-177.
    • (1996) Fam Med , vol.28 , Issue.3 , pp. 171-177
    • Cohen, J.A.1    Beall, D.G.2    Miller, D.W.3
  • 4
    • 0001001961 scopus 로고    scopus 로고
    • Pharmacoeconomic impact of injectable sumatriptan on migraine associated healthcare costs
    • Streator SE, Shearer SW. Pharmacoeconomic impact of injectable sumatriptan on migraine associated Healthcare costs. Am J Manag Care 1996;2:67-76.
    • (1996) Am J Manag Care , vol.2 , pp. 67-76
    • Streator, S.E.1    Shearer, S.W.2
  • 6
    • 0031799684 scopus 로고    scopus 로고
    • Migraine and reduced work performance: A population-based diary study
    • von Korff M, Stewart WF, Simon DJ, Lipton RB. Migraine and reduced work performance: a population-based diary study. Neurology 1998;50:1741-1745.
    • (1998) Neurology , vol.50 , pp. 1741-1745
    • Von Korff M1    Stewart, W.F.2    Simon, D.J.3    Lipton, R.B.4
  • 7
    • 8544274431 scopus 로고    scopus 로고
    • A multinational investigation of the impact of subcutaneous sumatriptan III. Workplace productivity and non-workplace activity
    • Cortelli P, Cahlof C Bouchard J, et al. A multinational investigation of the impact of subcutaneous sumatriptan III. Workplace productivity and non-workplace activity. PharmacoEconomics 1997:11(Suppl.1):35-42.
    • (1997) Pharmacoeconomics , vol.11 , Issue.SUPPL. 1 , pp. 35-42
    • Cortelli, P.1    Cahlof, C.2    Bouchard, J.3
  • 9
    • 0033057323 scopus 로고    scopus 로고
    • Indirect costs of migraine in a managed care population
    • Fishman P, Black L. Indirect costs of migraine in a managed care population. Cephalalgia 1999;19:50-57.
    • (1999) Cephalalgia , vol.19 , pp. 50-57
    • Fishman, P.1    Black, L.2
  • 10
    • 0033027024 scopus 로고    scopus 로고
    • Incremental absenteeism due to headaches in migraine: Results from the mig-access French national cohort
    • Michel P, Dartigues JF, Duru G, et al. Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort. Cephalalgia 1999;19(5):503-510.
    • (1999) Cephalalgia , vol.19 , Issue.5 , pp. 503-510
    • Michel, P.1    Dartigues, J.F.2    Duru, G.3
  • 11
    • 0033059144 scopus 로고    scopus 로고
    • Validation of a migraine work and productivity loss questionnaire for use in migraine studies
    • Davies GM, Santanello N, Gerth W, Lerner D, Block GA. Validation of a migraine work and productivity loss questionnaire for use in migraine studies. Cephalalgia 1999;19(5): 497-502.
    • (1999) Cephalalgia , vol.19 , Issue.5 , pp. 497-502
    • Davies, G.M.1    Santanello, N.2    Gerth, W.3    Lerner, D.4    Block, G.A.5
  • 12
    • 8544234245 scopus 로고    scopus 로고
    • A multi-national investigation of the impact of subcutaneous sumatriptan II: Health-related quality of life
    • Dahlof C, Bouchard J, Cortelli P, et al. A multi-national investigation of the impact of subcutaneous sumatriptan II: health-related quality of life. PharmacoEconomics 1997; 11(Suppl.1):24-34.
    • (1997) Pharmacoeconomics , vol.11 , Issue.SUPPL. 1 , pp. 24-34
    • Dahlof, C.1    Bouchard, J.2    Cortelli, P.3
  • 15
    • 0029127294 scopus 로고
    • The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine
    • Tfelt-Hansen P, Henry P, Mulder LJ, et al. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 1995;346:923-926.
    • (1995) Lancet , vol.346 , pp. 923-926
    • Tfelt-Hansen, P.1    Henry, P.2    Mulder, L.J.3
  • 16
    • 0026517266 scopus 로고
    • A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine
    • The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 1992;32:177-184.
    • (1992) Eur Neurol , vol.32 , pp. 177-184
  • 17
    • 0031921795 scopus 로고    scopus 로고
    • Tulfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel-group study
    • Myllylä VV, Havanka H, Herrala L, et al. Tulfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache 1998;38:201-207.
    • (1998) Headache , vol.38 , pp. 201-207
    • Myllylä, V.V.1    Havanka, H.2    Herrala, L.3
  • 18
    • 0025772871 scopus 로고
    • A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine
    • The Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol 1991;31:314-322.
    • (1991) Eur Neurol , vol.31 , pp. 314-322
  • 19
    • 0000165169 scopus 로고    scopus 로고
    • Comparison of the efficacy, safety and tolerability of oral eletriptan and cafergot for the acute treatment of migraine
    • Reches A. Comparison of the efficacy, safety and tolerability of oral eletriptan and cafergot for the acute treatment of migraine. Cephalalgia 1999;19:355.
    • (1999) Cephalalgia , vol.19 , pp. 355
    • Reches, A.1
  • 20
    • 0033043501 scopus 로고    scopus 로고
    • Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo
    • The Diclofenac-K/Sumatriptan Migraine Study Group. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. Cephalalgia 1999;19(4):232-240.
    • (1999) Cephalalgia , vol.19 , Issue.4 , pp. 232-240
  • 21
    • 0030905949 scopus 로고    scopus 로고
    • Guidelines for the diagnosis and management of migraine in clinical practice
    • Pryse-Phillips WEM, Dodick WD, Edmeads JG, et al. Guidelines for the diagnosis and management of migraine in clinical practice. Can Med Assoc J 1997;156:1273-1287.
    • (1997) Can Med Assoc J , vol.156 , pp. 1273-1287
    • Pryse-Phillips, W.E.M.1    Dodick, W.D.2    Edmeads, J.G.3
  • 22
    • 0025001986 scopus 로고
    • Drug induced headache
    • Mathews NT. Drug induced headache. Neurologic Clinics 1990;8:903-912.
    • (1990) Neurologic Clinics , vol.8 , pp. 903-912
    • Mathews, N.T.1
  • 23
    • 0033595523 scopus 로고    scopus 로고
    • An international study to assess reliability of the migraine disability assessment (MIDAS) score
    • Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 1999;53(5):988-994.
    • (1999) Neurology , vol.53 , Issue.5 , pp. 988-994
    • Stewart, W.F.1    Lipton, R.B.2    Whyte, J.3
  • 24
    • 0032407703 scopus 로고    scopus 로고
    • Oral rizatriptan versus oral sumatriptan: A direct comparative study in the acute treatment of migraine
    • Tfelt-Hansen P, Teal J. Rodriguez F, et al on behalf of the Rizatriptan 030 Study Group. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Headache 1998;38:748-755.
    • (1998) Headache , vol.38 , pp. 748-755
    • Tfelt-Hansen, P.1    Teal, J.2    Rodriguez, F.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.